MARSHALL WACE, LLP - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$7,545,000
+28.1%
162,861
-32.6%
0.06%
+121.4%
Q1 2019$5,888,000
+150.0%
241,490
+46.1%
0.03%
+16.7%
Q4 2018$2,355,000
+3040.0%
165,304
+1385.3%
0.02%
+2300.0%
Q3 2016$75,000
-89.5%
11,129
-92.9%
0.00%
-90.9%
Q2 2014$716,000156,9080.01%
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders